...
首页> 外文期刊>Heart and vessels: An international journal >Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study
【24h】

Association of lecithin-cholesterol acyltransferase activity measured as a serum cholesterol esterification rate and low-density lipoprotein heterogeneity with cardiovascular risk: a cross-sectional study

机译:以血清胆固醇酯化率和低密度脂蛋白异质性衡量的卵磷脂-胆固醇酰基转移酶活性与心血管疾病风险的关联:一项横断面研究

获取原文
获取原文并翻译 | 示例

摘要

The cholesterol-esterifying enzyme, lecithin-cholesterol acyltransferase (LCAT), is believed to play a key role in reverse cholesterol transport. However, recent investigations have demonstrated that higher LCAT activity levels increase the formation of triglyceride (TG)-rich lipoproteins (TRLs) and atherogenesis. We hypothesized that higher LCAT activity measured as a serum cholesterol esterification rate by the endogenous substrate method might increase the formation of TRLs and thereby alter low-density lipoprotein (LDL) heterogeneity. The estimated LDL particle size [relative LDL migration (LDL-Rm)] was measured by polyacrylamide gel electrophoresis with the LipoPhor system (Joko, Tokyo, Japan) in 538 consecutive patients with at least risk factor for atherosclerosis. Multivariate regression analysis after adjustments for traditional risk factors identified elevated TRL-related marker (TG, remnant-like particle cholesterol, apolipoprotein C-II, and apolipoprotein C-III) levels as independent predictors of smaller-sized LDL particle size, both in the overall subject population and in the subset of patients with serum LDL cholesterol levels of < 100 mg/dL. Area under the receiver operating characteristic curve of the LCAT activity (0.79; sensitivity 60 %; specificity 84.8 %) was observed for the evaluation of the indicators of an LDL-Rm value of a parts per thousand yen0.40, which suggests the presence of large amounts of small-dense LDL. The results lend support to the hypothesis that increased LCAT activity may be associated with increased formation of TRLs, leading to a reduction in LDL particle size. Therefore, to reduce the risk of atherosclerotic cardiovascular disease, it may be of importance to pay attention not only to a quantitative change in the serum LDL-C, but also to the LCAT activity which is possibly associated with LDL heterogeneity.
机译:胆固醇酯化酶卵磷脂-胆固醇酰基转移酶(LCAT)被认为在胆固醇逆向转运中起关键作用。但是,最近的研究表明,较高的LCAT活性水平会增加富含甘油三酸酯(TG)的脂蛋白(TRL)的形成和动脉粥样硬化。我们假设通过内源底物方法测得的较高的LCAT活性(以血清胆固醇酯化率衡量)可能会增加TRL的形成,从而改变低密度脂蛋白(LDL)的异质性。估计的LDL粒径[相对LDL迁移(LDL-Rm)]是通过使用LipoPhor系统(Joko,东京,日本)通过聚丙烯酰胺凝胶电泳对538例至少具有动脉粥样硬化危险因素的患者进行测量的。调整传统危险因素后的多变量回归分析确定,升高的TRL相关标记(TG,残留样颗粒胆固醇,载脂蛋白C-II和载脂蛋白C-III)水平是较小LDL粒径的独立预测因子,两者总体受试者人群以及血清LDL胆固醇水平<100 mg / dL的患者子集。观察到接收者的LCAT活性的工作特性曲线下的面积(0.79;灵敏度为60%;特异性为84.8%),以评估每千日元份的LDL-Rm值指标为0.40,表明存在大量的小密度LDL。该结果支持以下假设:LCAT活性增加可能与TRL的形成增加有关,从而导致LDL粒径减小。因此,为了降低动脉粥样硬化性心血管疾病的风险,不仅要注意血清LDL-C的定量变化,而且要注意可能与LDL异质性有关的LCAT活性,这一点可能很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号